<div id="readability-page-1">04:44 PM EDT, 05/12/2026 (MT Newswires) -- SELLAS Life Sciences Group ( SLS ) reported a Q1 loss late Tuesday of $0.05 per diluted share, narrowing from a loss of $0.07 a year earlier.Two analysts polled by FactSet expected a loss of $0.06.Cash and cash equivalents were $107.1 million at the end of Q1, compared with $71.8 million at the end of Q4.Shares of the company rose more than 12% in after-hours activity. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

2026 年 5 月 12 日下午 4:44（东部夏令时间）——SELLAS Life Sciences Group（SLS）在周二晚间报告了第一季度每股摊薄亏损 0.05 美元，较去年同期的 0.07 美元亏损有所收窄。根据 FactSet 的调查，两位分析师预计亏损为 0.06 美元。第一季度末现金及现金等价物为 1.071 亿美元，而第四季度末为 7180 万美元。该公司股票在盘后交易中上涨超过 12%。MT Newswires 不提供投资建议。未经授权的复制严格禁止

Sellas Life Sciences 集团第一季度亏损收窄